Surufatinib
Tier C — Watch / tradeSurufatinib
Targets：FGFR1, CSF1R, VEGFR
Brand：SULANDA
Indications (approved)：Neuroendocrine tumour
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| SULFA-001 | 13314-85-7 | 2-methyl-1H-indol-5-ol |
| SULFA-002 | 3934-20-1Available | 2,4-dichloropyrimidine |
| SULFA-003 | 1071105-16-2 | 5-((2-chloropyrimidin-4-yl)oxy)-2-methyl-1H-indole |
| SULFA-004 | 1094797-87-1 | 1-(3-aminophenyl)-N-(2-(dimethylamino)ethyl)methanesulfonamide |
| Sulfatinib | 1308672-74-3 | - |
Frequently asked questions
What are the approved indications of Surufatinib?
Approved indications include: Neuroendocrine tumour.
When does the Surufatinib patent expire?
No public expiry year is available for Surufatinib yet; this page updates once verified.
How many synthesis routes are recorded for Surufatinib?
1 synthesis routes are recorded; the shortest is 2 steps with 1.07 kg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Surufatinib intermediates?
1 intermediate CAS of Surufatinib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Surufatinib intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29